Dexcom Announces Upcoming Virtual Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming virtual investor conferences:
- Quentin Blackford, Chief Operating Officer and Chief Financial Officer, will present on behalf of the company at the Citi 2021 Healthcare Services, Medtech, Tools and HCIT Virtual Conference on Wednesday, February 24, 2021 at 1:30pm (EST).
- Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the SVB Leerink 10th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 3:40pm (EST).
- Jereme Sylvain, Senior Vice President, Finance and Chief Accounting Officer, will present on behalf of the company at the Raymond James Institutional Investors Conference on Monday, March 1, 2021 at 10:50am (EST).
Links to the webcasts will be available on the Dexcom Investor Relations website at investors.dexcom.com/ and will be archived there for future reference.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005144/en/
Dexcom Inc. Stock
With 18 Buy predictions and not the single Sell prediction the community is currently very high on Dexcom Inc..
Based on the current price of 63.49 € the target price of 134 € shows a potential of 111.06% for Dexcom Inc. which would more than double the current price.
